Staying The Course: PhRMA Announces ‘Pro-Consumer’ Reform Priorities

Recently installed CEO Stephen Ubl presents policy solutions as industry’s best response to ongoing public criticism over high drug prices.

The Pharmaceutical Research and Manufacturers Association’s policy priorities for the coming year include a set of long-held objectives packaged with some newer ones as solutions “for delivering innovative care to patients.”

Recently installed PhRMA President and CEO Stephen Ubl outlined the priorities at the association’s annual meeting March 10, maintaining they represent the “right way” to address the challenges of rising...

More from United States

More from North America